Ion Beam Applications S.A. (IOBCF)
IOBCF Stock Price Chart
Explore Ion Beam Applications S.A. interactive price chart. Choose custom timeframes to analyze IOBCF price movements and trends.
IOBCF Company Profile
Discover essential business fundamentals and corporate details for Ion Beam Applications S.A. (IOBCF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
24 Sept 2001
Employees
2.12K
Website
https://www.iba-worldwide.comCEO
Olivier Legrain
Description
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for advance research in ConformalFLASH. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
IOBCF Financial Timeline
Browse a chronological timeline of Ion Beam Applications S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 28 Aug 2025
EPS came in at -$0.11 surpassing the estimated -$0.11 by +0.06%, while revenue for the quarter reached $359.10M , missing expectations by -0.05%.
Earnings released on 22 May 2025
EPS came in at $0.68 surpassing the estimated $0.60 by +13.17%, while revenue for the quarter reached $302.06M , beating expectations by +19.09%.
Dividend declared on 20 Mar 2025
A dividend of $0.28 per share was announced, adjusted to $0.32. The dividend was paid on 1 Jul 2025.
Earnings released on 21 Nov 2024
EPS came in at -$0.38 falling short of the estimated -$0.13 by -195.53%, while revenue for the quarter reached $221.99M , missing expectations by -1.78%.
Earnings released on 23 May 2024
EPS came in at $0.69 , while revenue for the quarter reached $285.17M , beating expectations by +3.35%.
Dividend declared on 21 Mar 2024
A dividend of $0.18 per share was announced, adjusted to $0.20. The dividend was paid on 24 Jun 2024.
Earnings released on 30 Jun 2023
EPS came in at -$1.02 , while revenue for the quarter reached $184.82M .
Dividend declared on 23 Mar 2023
A dividend of $0.23 per share was announced, adjusted to $0.25. The dividend was paid on 3 Jul 2023.
Earnings released on 31 Dec 2022
EPS came in at $0.28 , while revenue for the quarter reached $216.77M .
Earnings released on 30 Jun 2022
EPS came in at -$0.06 , while revenue for the quarter reached $167.40M .
Dividend declared on 27 May 2022
A dividend of $0.20 per share was announced, adjusted to $0.21. The dividend was paid on 1 Jul 2022.
Earnings released on 31 Dec 2021
EPS came in at $0.22 , while revenue for the quarter reached $199.28M .
Earnings released on 30 Jun 2021
EPS came in at -$0.08 , while revenue for the quarter reached $162.76M .
Dividend declared on 16 Jun 2021
A dividend of $0.24 per share was announced, adjusted to $0.28. The dividend was paid on 23 Jun 2021.
Earnings released on 31 Dec 2020
EPS came in at $1.82 , while revenue for the quarter reached $248.00M .
IOBCF Stock Performance
Access detailed IOBCF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.